FDA Menopause Hearing: What You Missed and Why It Matters скачать в хорошем качестве

FDA Menopause Hearing: What You Missed and Why It Matters

The FDA just held one of its most important public hearings on menopause and hormone therapy in decades. From systemic barriers to outdated warnings on vaginal estrogen, this expert panel laid the groundwork for major change in women’s health. 💡 In this video, I break down key takeaways: Why the boxed warning on vaginal estrogen may finally be lifted Testosterone for women: what the evidence really shows Jim Simon’s powerful commentary on women’s unmet needs The missing conversation about progesterone — and why it matters The bigger picture: how regulation, research, reimbursement, and clinician training must work together 🎙️ Featuring insights from: Rachel Rubin, JoAnn Manson, Barbara Levy, Mary Jane Minkin, James Simon, Heather Hirsch, Roberta Brinton, and more. 🔗 Resources & Links Full FDA Panel Recording: https://www.youtube.com/live/_2ZRlOivC5M Public Comment Open Through September 24, 2025: https://www.regulations.gov/document/... Click on "comment" at the top of the page. Unboxing Menopause Campaign: https://www.letstalkmenopause.org/unb... Sign up for the Fempower Health newsletter: https://www.fempower-health.com/newsl... 📌 Subscribe to stay informed on the systemic forces shaping women’s health. 💬 Drop a comment: What surprised you most about the hearing? #Menopause #HormoneTherapy #FDA #WomensHealth #HRT #VaginalEstrogen #TestosteroneForWomen #Progesterone #FempowerHealth #UnboxingMenopause